Sameer Kadri
@SameerKadri12
Followers
452
Following
446
Statuses
205
Critcare/ID Doc & Clin Epidemiolog @NIHCritCare, Dedicated to improving outcomes from lethal infections & AMR🏳️🌈Opinions are my own
Bethesda, MD
Joined June 2020
0
0
0
@morgan_walker4 rocking the seminar stage at Harvard Population Medicine sharing her work integrating antibiotic access into AMR burdens! Proud of you. @NIHCritCare @JHMed_ID
0
2
13
RT @ABsteward: 🆕️🔥Retrospective cohort study with target trial emulation Adult patients with invasive GAS infections treated with β-lactam,…
0
35
0
RT @RAmirahmadi: Had a great session on #AI in #MedEd alongside @ChrisCarrollMD, @vanholdenmd and Sami Safadi at @accpchest! I focused on h…
0
8
0
Honored to offer clinical perspectives on AMR to antibiotic developers at @ESCMID / @ASMicrobiology conference in Porto. @NIHCritCare @NIHClinicalCntr #AMR
0
1
10
RT @ESCMID: The symposium on antimicrobial stewardship kicks off our 4th day at the ESCMID/@ASMicrobiology Conference in Porto! Thank you…
0
4
0
Congratulations to study leads @ManirajNeupane @sarahrenee314
@NIHCritCare @ASPRgov #COVID19 @HosDisasPrepRNG @HospitalPrepare @ahahospitals @CDCemergency @ndms @TheNETEC @NACCHOalerts @EMS1 @RMavesMd @vxm16 @georgeanesi @nickmmark
0
0
2
Was a privilege to record this podcast with Dr Centor for @AnnalsofIM Annals on call.
In this new episode of Annals On Call, Dr. Centor @medrants discusses uptake of newer #antibiotics for treatment-resistant infections with @SameerKadri12:
1
1
11
@JeremyLDavisMD @nbartellmd @CGAIGC @JAMA_current Great work! Congratulations @JeremyLDavisMD and team!
0
0
1
Congrats Mani! You will do great things. NIH is proud of you @ManirajNeupane @NIHCritCare
0
0
6
RT @NIHCritCare: We are so proud of our 2024 Critical Care Medicine graduating fellows! Congratulations @ManirajNeupane, @YasirHamad11, @mo…
0
4
0
@hboucher3 and I discuss antibiotic resistance on @NPR Morning Edition “..this can’t be our new normal…” @NIHClinicalCntr @NIHCritCare @TuftsMedicalCtr #amr #covid
0
0
9
0
0
0
0
0
0
@ABsteward @BradSpellberg @DrToddLee @medrants @PulmCrit Are there implications to changing management? If not then why budge from using primary and secondary BSI. There is a cost to too many terms in historical literature that point to the same thing.
1
1
3
Scary 🫣: ~1 in 6 Gram negative isolates in India is resistant to last-line antibiotic (polymyxins) based on this systematic review. #amr @gardp_amr @WHO
2
4
10
Carbapenems Overused for Drug-Resistant Enterobacterales Infections @chc_yek @sarahrenee314 @NIHCritCare @NIHClinicalCntr @IDSAInfo Congrats to lead author @morgan_walker4 !
0
3
9
0
0
1